Department of Bacteriology, Faculty of Medical Science, Tarbiat Modares University, Tehran, Iran.
Department of Bacteriology, Faculty of Medical Science, Tarbiat Modares University, Tehran, Iran.
Microb Pathog. 2022 Dec;173(Pt A):105860. doi: 10.1016/j.micpath.2022.105860. Epub 2022 Oct 29.
The increasing prevalence of vancomycin-resistant Enterococcus faecium, along with the ability of this bacterium to form biofilm on biotic surfaces and medical devices, has created a serious challenge. Therefore, the development of new antibacterial agents is an urgent need. In this study, curcumin carbon dots (Cur-CDs) were synthesized by a one-step hydrothermal method, and its antibacterial and antibiofilm effects were investigated. By broth microdilution method, the minimal inhibitory concentration (MIC) against vancomycin-resistant and sensitive clinical isolates of Enterococcus faecium (two clinical isolates in total) and standard strain of Enterococcus faecalis ATCC 29212 was determined, which were 1000, 1000, and 125 μg/ml, respectively. The inhibitory effect of Cur-CDs on biofilm formation of vancomycin-resistant E. faecium clinical isolates were evaluated by microtiter plate assay. Cur-CDs (1000 μg/ml) significantly prevented (p = 0.009) the biofilm formation of E. faecium isolates. Real-time PCR results showed that Cur-CDs (1000 μg/ml) significantly downregulated the expression of esp and gelE genes (p = 0.001 and p = 000000002, respectively) in clinical isolates of E. faecium, while Cur-CDs did not affect acm gene expression (p = 0.086). This study revealed that Cur-CDs can be effective antibacterial and antibiofilm agents against vancomycin-resistant and biofilm producer E. faecium, which makes them interesting candidates for treating or preventing bacterial infections.
万古霉素耐药粪肠球菌(Vancomycin-resistant Enterococcus faecium,VRE)的发病率不断上升,加之该细菌能够在生物表面和医疗设备上形成生物膜,这给医疗带来了严重挑战。因此,开发新型抗菌药物迫在眉睫。本研究采用一步水热法合成姜黄素碳点(Curcumin carbon dots,Cur-CDs),并对其抗菌和抗生物膜作用进行了研究。通过肉汤微量稀释法,确定了 Cur-CDs 对万古霉素耐药和敏感临床粪肠球菌分离株(共 2 株临床分离株)和标准粪肠球菌 ATCC 29212 的最小抑菌浓度(minimal inhibitory concentration,MIC)分别为 1000、1000 和 125 μg/ml。通过微量滴定板试验评估了 Cur-CDs 对万古霉素耐药粪肠球菌临床分离株生物膜形成的抑制作用。Cur-CDs(1000 μg/ml)可显著抑制粪肠球菌分离株的生物膜形成(p=0.009)。实时 PCR 结果显示,Cur-CDs(1000 μg/ml)可显著下调粪肠球菌临床分离株 esp 和 gelE 基因的表达(p=0.001 和 p=0.000000002),而 Cur-CDs 对 acm 基因的表达无影响(p=0.086)。本研究表明,Cur-CDs 可有效抑制万古霉素耐药且产生物膜的粪肠球菌,是治疗或预防细菌感染的潜在药物。